Overview
Lisa Rouson is a Nurse Practitioner in Hackettstown, New Jersey. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer. Ms. Rouson is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
651 Willow Grove St, Hackettstown, NJ 07840
100 Madison Ave, Morristown, NJ 07960
Natalia Cherkassky is a Nurse Practitioner in Fair Lawn, New Jersey. Ms. Cherkassky is highly rated in 1 condition, according to our data. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Lehigh Valley Physician Group
Jean Cain is a Nurse Practitioner in Allentown, Pennsylvania. Ms. Cain is highly rated in 2 conditions, according to our data. Her top areas of expertise are Relapsing Multiple Sclerosis (RMS) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
David Mendoza is a Nurse Practitioner in New York, New York. Mr. Mendoza is highly rated in 1 condition, according to our data. His top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Rouson isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.